PL140526B1 - Process for preparing novel substituted 1,4-dihydropyridines - Google Patents

Process for preparing novel substituted 1,4-dihydropyridines Download PDF

Info

Publication number
PL140526B1
PL140526B1 PL1983245200A PL24520083A PL140526B1 PL 140526 B1 PL140526 B1 PL 140526B1 PL 1983245200 A PL1983245200 A PL 1983245200A PL 24520083 A PL24520083 A PL 24520083A PL 140526 B1 PL140526 B1 PL 140526B1
Authority
PL
Poland
Prior art keywords
dimethyl
dihydro
melting point
methyl
group
Prior art date
Application number
PL1983245200A
Other languages
English (en)
Polish (pl)
Other versions
PL245200A1 (en
Inventor
Karl Schoenafinger
Helmut Bohn
Melitta Just
Piero Martorana
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of PL245200A1 publication Critical patent/PL245200A1/xx
Publication of PL140526B1 publication Critical patent/PL140526B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • Protection Of Plants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL1983245200A 1982-12-20 1983-12-19 Process for preparing novel substituted 1,4-dihydropyridines PL140526B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823247118 DE3247118A1 (de) 1982-12-20 1982-12-20 Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
PL245200A1 PL245200A1 (en) 1985-02-27
PL140526B1 true PL140526B1 (en) 1987-05-30

Family

ID=6181182

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1983245200A PL140526B1 (en) 1982-12-20 1983-12-19 Process for preparing novel substituted 1,4-dihydropyridines

Country Status (20)

Country Link
US (1) US4558058A (forum.php)
EP (1) EP0116708B1 (forum.php)
JP (1) JPS59118783A (forum.php)
KR (1) KR840006969A (forum.php)
AT (1) ATE19776T1 (forum.php)
AU (1) AU562583B2 (forum.php)
CA (1) CA1194480A (forum.php)
CS (1) CS241144B2 (forum.php)
DD (1) DD215548A5 (forum.php)
DE (2) DE3247118A1 (forum.php)
DK (1) DK562683A (forum.php)
ES (1) ES8406193A1 (forum.php)
FI (1) FI834451A7 (forum.php)
GR (1) GR79484B (forum.php)
HU (1) HU194556B (forum.php)
NO (1) NO834480L (forum.php)
PH (1) PH20327A (forum.php)
PL (1) PL140526B1 (forum.php)
SU (1) SU1360585A3 (forum.php)
ZA (1) ZA839382B (forum.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
DE3431862A1 (de) * 1984-08-30 1986-03-13 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5326772A (en) * 1984-09-28 1994-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Diaryl compounds for their use
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−1,4−ジヒドロピリジン誘導体
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
DE3883627D1 (de) * 1987-03-27 1993-10-07 Byk Gulden Lomberg Chem Fab 1,4-Dihydropyridin-Enantiomere.
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US7312337B2 (en) * 2004-09-30 2007-12-25 Eastman Kodak Company Oxadiazoles and their manufacture
DE102006044696A1 (de) * 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647809A (en) * 1968-04-26 1972-03-07 Chinoin Gyogyszer Es Vegyeszet Certain pyridyl-1 2 4-oxadiazole derivatives
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
CA962269A (en) * 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use

Also Published As

Publication number Publication date
GR79484B (forum.php) 1984-10-30
ATE19776T1 (de) 1986-05-15
DK562683D0 (da) 1983-12-06
AU562583B2 (en) 1987-06-11
PH20327A (en) 1986-12-02
EP0116708A1 (de) 1984-08-29
FI834451A7 (fi) 1984-06-21
FI834451A0 (fi) 1983-12-05
JPS59118783A (ja) 1984-07-09
DD215548A5 (de) 1984-11-14
KR840006969A (ko) 1984-12-04
PL245200A1 (en) 1985-02-27
HU194556B (en) 1988-02-29
AU2253383A (en) 1984-06-28
CA1194480A (en) 1985-10-01
ES528175A0 (es) 1984-08-01
NO834480L (no) 1984-06-21
DE3363545D1 (en) 1986-06-19
ZA839382B (en) 1984-08-29
SU1360585A3 (ru) 1987-12-15
DE3247118A1 (de) 1984-06-20
US4558058A (en) 1985-12-10
DK562683A (da) 1984-06-21
ES8406193A1 (es) 1984-08-01
EP0116708B1 (de) 1986-05-14
CS961383A2 (en) 1985-07-16
CS241144B2 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
PL140526B1 (en) Process for preparing novel substituted 1,4-dihydropyridines
US4492703A (en) 4-(2-Substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid esters active on blood circulation
CA2178413A1 (en) Dihydropyridine npy antagonists: piperazine derivatives
EP2256115A1 (en) Heteromonocyclic compound and use thereof
JPH0225913B2 (forum.php)
US4705786A (en) Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents
US5486531A (en) Hydroxymethylfurazancarboxylic acid derivatives
HU195199B (en) Process for producing pharmaceutical compositions containing 3-aminosidnonimine derivatives and the active agents
EP0080220A1 (en) Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
JPS61257983A (ja) 1,4−ジヒドロピリジン及びこれを有効成分とする医薬組成物
US4760147A (en) Optically active, substituted 1,4-dihydropyridines and their use as medicaments
US5424326A (en) Phenyl-1,2,5-oxadiazolecarboxamide-2-oxides, their preparation and their use
US5374640A (en) Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
US4681891A (en) Dihydro-2,6-dimethyl pyridines, formulations and method of use for treating angina pectoris, high blood pressure or disturbances of cerebral or peripheral blood flow
US5389655A (en) Phenylfuroxans
AU764627B2 (en) Dihydropyrazine derivatives as NPY antagonists
US4910195A (en) Dihydropyridine derivatives
US6596724B2 (en) Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists
HU188342B (en) Process for preparing new dihydropyridine derivatives
CA2353897A1 (en) 1,4-benzodiazepinone derivatives and their use as integrin antagonists
DE4401150A1 (de) Furazancarbonsäurederivate
DE3707236A1 (de) Nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln